Gene · 3799
Papers2,390
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,390
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Metastatic Pulmonary Sarcomatoid Carcinoma Patient Harboring KIF5B-RET Fusion Responds to First-Line Pralsetinib Treatment: A Case Report. | Cancer Manag Res | 2023 | 37525669 | PubTator, text mining | PubMed |
| Vesicle-mediated transport of ALIX and ESCRT-III to the intercellular bridge during cytokinesis. | Cell Mol Life Sci | 2023 | 37523003 | PubTator, text mining | PubMed |
| Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset. | Transl Oncol | 2023 | 37516008 | PubTator, text mining | PubMed |
| Personalized Medicine in Medullary Thyroid Carcinoma: A Broad Review of Emerging Treatments. | J Pers Med | 2023 | 37511745 | PubTator, text mining | PubMed |
The Role of Mitochondrial Dynamics and Mitotic Fission in Regulating the Cell Cycle in Cancer and Pulmonary Arterial Hypertension: Implications for Dynamin-Related Protein 1 and Mitofusin2 in Hyperproliferative Diseases. | Cells | 2023 | 37508561 | PubTator, text mining | PubMed |
| Small bowel edema and lymphocytic duodenitis as severe reversible gastrointestinal toxicity of selpercatinib in RET fusion-positive non-small cell lung cancer: a case report. | Front Oncol | 2023 | 37492479 | PubTator, text mining | PubMed |
| Rab6-mediated retrograde trafficking from the Golgi: the trouble with tubules. | Small GTPases | 2023 | 37488775 | PubTator, text mining | PubMed |
| HURP localization in metaphase is the result of a multi-step process requiring its phosphorylation at Ser627 residue. | Front Cell Dev Biol | 2023 | 37484914 | PubTator, text mining | PubMed |
| A functional sgRNA-CRISPR screening method for generating murine RET and NTRK1 rearranged oncogenes. | Biol Open | 2023 | 37470475 | PubTator, text mining | PubMed |
| Important roles of Hif1a in maternal or adult BPA exposure induced pancreatic injuries. | Sci Rep | 2023 | 37460698 | PubTator, text mining | PubMed |
| Osteoarthritis related epigenetic variations in miRNA expression and DNA methylation. | BMC Med Genomics | 2023 | 37434153 | PubTator, text mining | PubMed |
| Centrosome amplification fine tunes tubulin acetylation to differentially control intracellular organization. | EMBO J | 2023 | 37403793 | PubTator, text mining | PubMed |
| A human proteogenomic-cellular framework identifies KIF5A as a modulator of astrocyte process integrity with relevance to ALS. | Commun Biol | 2023 | 37386082 | PubTator, text mining | PubMed |
| Re: "A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion" by Wijewardene et al. | Thyroid | 2023 | 37376747 | PubTator, text mining | PubMed |
| Small Molecule Inhibitors as Therapeutic Agents Targeting Oncogenic Fusion Proteins: Current Status and Clinical. | Molecules | 2023 | 37375228 | PubTator, text mining | PubMed |
| Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story? | Int J Mol Sci | 2023 | 37373267 | PubTator, text mining | PubMed |
| Precision oncology with selective RET inhibitor selpercatinib in RET-rearranged cancers. | Ther Adv Med Oncol | 2023 | 37360768 | PubTator, text mining | PubMed |
| Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours. | Target Oncol | 2023 | 37347391 | PubTator, text mining | PubMed |
| Molecular alterations of driver genes in non-small cell lung cancer: from diagnostics to targeted therapy. | EXCLI J | 2023 | 37346803 | PubTator, text mining | PubMed |
| Chaperonin CCT controls extracellular vesicle production and cell metabolism through kinesin dynamics. | J Extracell Vesicles | 2023 | 37328936 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3799/papers?page=13